Pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam in peritoneal fluid in an orthotopic liver transplant recipient affected by bacteraemic complicated intra-abdominal infection due to OXA-181-producing Klebsiella pneumoniae

J Glob Antimicrob Resist. 2023 Sep:34:268-270. doi: 10.1016/j.jgar.2023.05.007. Epub 2023 Jun 1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ascitic Fluid
  • Azabicyclo Compounds / pharmacology
  • Azabicyclo Compounds / therapeutic use
  • Ceftazidime / pharmacology
  • Drug Combinations
  • Humans
  • Intraabdominal Infections* / drug therapy
  • Klebsiella pneumoniae
  • Liver Transplantation*

Substances

  • avibactam, ceftazidime drug combination
  • Ceftazidime
  • Drug Combinations
  • Azabicyclo Compounds